Medicines Australia is pleased to welcome the appointment of Professor Andrew Wilson as incoming Chair of the Pharmaceutical Benefits Advisory Committee (PBAC).

MA also welcomes the appointments of Dr Peter Grimison and Professor Jonathan Craig as members of the Committee.

“I would like to congratulate all the new members on their appointments,” said Medicines Australia CEO, Tim James.

“Professor Wilson has enormous experience in the health sector and as a former member of PBAC will be well prepared for the demanding role of Chair.

“Medicines Australia looks forward to a collaborative, pragmatic and patient focused PBAC under Professor Wilson’s stewardship.

“He has shown a willingness to engage with the medicines industry and has a deep understanding of the issues impacting on our sector.

For more details, go to: https://medicinesaustralia.com.au/media-release/medicines-australia-welcomes-new-chair-and-members-of-the-pharmaceutical-benefits-advisory-committee-pbac/